{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:13:15Z","timestamp":1783573995258,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fuyang Health Research Project","award":["FYZC2024 - 038"],"award-info":[{"award-number":["FYZC2024 - 038"]}]},{"name":"the Natural Science Foundation of Higher Education Institutions of Anhui Province","award":["KJ2021A0352"],"award-info":[{"award-number":["KJ2021A0352"]}]},{"name":"The Research Fund Project of Anhui Medical University","award":["2020xkj236"],"award-info":[{"award-number":["2020xkj236"]}]},{"name":"The Applied Medicine Research Project of Hefei Health Commission","award":["HWKJ2019-172-14"],"award-info":[{"award-number":["HWKJ2019-172-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04378-4","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:25:33Z","timestamp":1777112733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["REBACIN\u00ae can remove high-risk Human Papillomavirus (HPV) persistent infection efficiently as an effective non-invasive treatment: a multicenter prospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie-Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Shuai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Feng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Guang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"4378_CR1","doi-asserted-by":"crossref","unstructured":"Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key Molecular Events in Cervical Cancer Development. Med (Kaunas). 2019;55(7):384.","DOI":"10.3390\/medicina55070384"},{"issue":"7","key":"4378_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnci\/djn044","volume":"100","author":"AC Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst. 2008;100(7):513\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"4378_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"9","key":"4378_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/aogs.12197","volume":"92","author":"B Kirschner","year":"2013","unstructured":"Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D, Schledermann D. HPV genotypes in invasive cervical cancer in Danish women. Acta Obstet Gynecol Scand. 2013;92(9):1023\u201331.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"4378_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1161\/CIRCRESAHA.118.313779","volume":"124","author":"EJ Joo","year":"2019","unstructured":"Joo EJ, Chang Y, Kwon MJ, Cho A, Cheong HS, Ryu S. High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women. Circul Res. 2019;124(5):747\u201356.","journal-title":"Circul Res"},{"issue":"12","key":"4378_CR6","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/eurheartj\/ehae020","volume":"45","author":"HS Cheong","year":"2024","unstructured":"Cheong HS, Chang Y, Kim Y, Kwon MJ, Cho Y, Kim B, Joo EJ, Bae YH, Kim C, Ryu S. Human papillomavirus infection and cardiovascular mortality: a cohort study. Eur Heart J. 2024;45(12):1072\u201382.","journal-title":"Eur Heart J"},{"key":"4378_CR7","doi-asserted-by":"crossref","unstructured":"Tonhajzerova I, Olexova LB, Jurko A Jr., Spronck B, Jurko T, Sekaninova N, Visnovcova Z, Mestanikova A, Kudela E, Mestanik M. Novel Biomarkers of Early Atherosclerotic Changes for Personalised Prevention of Cardiovascular Disease in Cervical Cancer and Human Papillomavirus Infection. Int J Mol Sci. 2019;20(15):3720.","DOI":"10.3390\/ijms20153720"},{"key":"4378_CR8","doi-asserted-by":"crossref","unstructured":"Schubert M, Bauerschlag DO, Muallem MZ, Maass N, Alkatout I. Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer. Med (Kaunas Lithuania). 2023;59(5):925.","DOI":"10.3390\/medicina59050925"},{"issue":"1","key":"4378_CR9","doi-asserted-by":"publisher","first-page":"15875","DOI":"10.1038\/s41598-024-65842-3","volume":"14","author":"RM Stuart","year":"2024","unstructured":"Stuart RM, Cohen JA, Abeysuriya RG, Sanz-Leon P, Kerr CC, Rao D, Klein DJ. Inferring the natural history of HPV from global cancer registries: insights from a multi-country calibration. Sci Rep. 2024;14(1):15875.","journal-title":"Sci Rep"},{"issue":"1","key":"4378_CR10","doi-asserted-by":"publisher","first-page":"e2176009","DOI":"10.1080\/22221751.2023.2176009","volume":"12","author":"X Yang","year":"2023","unstructured":"Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X, He T, Yin A, Luo M. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infect. 2023;12(1):e2176009.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"4378_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12916-025-03975-6","volume":"23","author":"S Han","year":"2025","unstructured":"Han S, Lin M, Liu M, Wu S, Guo P, Guo J, Xie L, Qiu S, Xu A, Cai Y, et al. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med. 2025;23(1):158.","journal-title":"BMC Med"},{"key":"4378_CR12","doi-asserted-by":"crossref","unstructured":"Scarth JA, Patterson MR, Morgan EL, Macdonald A. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol. 2021;102(3):001540.","DOI":"10.1099\/jgv.0.001540"},{"issue":"17","key":"4378_CR13","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (London England: 1979). 2017;131(17):2201\u201321.","journal-title":"Clin Sci (London England: 1979)"},{"issue":"1","key":"4378_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.30623","volume":"141","author":"SR Hoffman","year":"2017","unstructured":"Hoffman SR, Le T, Lockhart A, Sanusi A, Dal Santo L, Davis M, McKinney DA, Brown M, Poole C, Willame C, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review. Int J Cancer. 2017;141(1):8\u201323.","journal-title":"Int J Cancer"},{"issue":"10","key":"4378_CR15","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaoncol.2021.2683","volume":"7","author":"MH Chung","year":"2021","unstructured":"Chung MH, De Vuyst H, Greene SA, Mugo NR, Querec TD, Nyongesa-Malava E, Cagle A, Sakr SR, Luchters S, Temmerman M, et al. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2021;7(10):1514\u201320.","journal-title":"JAMA Oncol"},{"key":"4378_CR16","doi-asserted-by":"publisher","first-page":"1047222","DOI":"10.3389\/fonc.2022.1047222","volume":"12","author":"SG Zhou","year":"2022","unstructured":"Zhou SG, Wu DF, Yao H, Zhang WY, Tian FJ, Chen G, Zhang CF. REBACIN(\u00ae) inhibits E6\/E7 oncogenes in clearance of human papillomavirus infection. Front Oncol. 2022;12:1047222.","journal-title":"Front Oncol"},{"issue":"10","key":"4378_CR17","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1002\/ijc.32344","volume":"145","author":"Y Yang","year":"2019","unstructured":"Yang Y, Meng YL, Duan SM, Zhan SB, Guan RL, Yue TF, Kong LH, Zhou L, Deng LH, Huang C, et al. REBACIN\u00ae as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection. Int J Cancer. 2019;145(10):2712\u20139.","journal-title":"Int J Cancer"},{"issue":"12","key":"4378_CR18","doi-asserted-by":"publisher","first-page":"e81366","DOI":"10.1371\/journal.pone.0081366","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Li S, Yan Q, Chen X, Yang Y, Liu X, Wan X. Interferon-\u03b2 induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS ONE. 2013;8(12):e81366.","journal-title":"PLoS ONE"},{"issue":"2","key":"4378_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/02656736.2021.1910736","volume":"38","author":"W Wang","year":"2021","unstructured":"Wang W, Liu Y, Pu Y, Li C, Zhou H, Wang Z. Effectiveness of focused ultrasound for high risk human papillomavirus infection-related cervical lesions. Int J Hyperth. 2021;38(2):96\u2013102.","journal-title":"Int J Hyperth"},{"key":"4378_CR20","doi-asserted-by":"publisher","first-page":"114686","DOI":"10.1016\/j.ejogrb.2025.114686","volume":"314","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Lv S, Liu F. Combined therapy for LSIL with HR-HPV: CO(2) laser and interferon \u03b12a. Eur J Obstet Gynecol Reprod Biol. 2025;314:114686.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"4378_CR21","first-page":"995","volume":"39","author":"Expert Panel on Cervical Disease CSfCaCPC","year":"2023","unstructured":"Expert Panel on Cervical Disease CSfCaCPC. Expert consensus on the diagnosis and treatment of lower genital tract human papillomavirus infection (2023 edition). Chin J Practical Gynecol Obstet. 2023;39(10):995\u20131002. [In Chinese].","journal-title":"Chin J Practical Gynecol Obstet"},{"issue":"15","key":"4378_CR22","first-page":"1654","volume":"19","author":"P Wu","year":"2020","unstructured":"Wu P, Qiu L. Efficacy and safety of recombinant human interferon \u03b1-2b in the treatment of cervical HPV infection and its effect on vaginal microecology. J Clin Experimental Med. 2020;19(15):1654\u20137. [In Chinese].","journal-title":"J Clin Experimental Med"},{"issue":"10","key":"4378_CR23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.5858\/arpa.2018-0603-CP","volume":"143","author":"DD Davey","year":"2019","unstructured":"Davey DD, Souers RJ, Goodrich K, Mody DR, Tabbara SO, Booth CN. Bethesda 2014 Implementation and Human Papillomavirus Primary Screening: Practices of Laboratories Participating in the College of American Pathologists PAP Education Program. Arch Pathol Lab Med. 2019;143(10):1196\u2013202.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"4378_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","volume":"137","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516\u201342.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"4378_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/14737159.2015.961915","volume":"15","author":"R Zappacosta","year":"2015","unstructured":"Zappacosta R, Gatta DM, Marinucci P, Capanna S, Lattanzio G, Caraceni D, Rosini S. Role of E6\/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system. Expert Rev Mol Diagn. 2015;15(1):137\u201350.","journal-title":"Expert Rev Mol Diagn"},{"issue":"10","key":"4378_CR26","first-page":"e2414018","volume":"12","author":"X Qi","year":"2025","unstructured":"Qi X, Zhou J, Wang X, Shen Y, Cao Y, Jiang L, Shen M, Zhang H, Wang T, Wei P et al. HPV E6\/E7-Induced Acetylation of a Peptide Encoded by a Long Non-Coding RNA Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2025;12(10):e2414018.","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"2","key":"4378_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.67770","volume":"18","author":"C Hu","year":"2022","unstructured":"Hu C, Liu T, Han C, Xuan Y, Jiang D, Sun Y, Zhang X, Zhang W, Xu Y, Liu Y, et al. HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression. Int J Biol Sci. 2022;18(2):507\u201321.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"4378_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ygyno.2019.05.026","volume":"154","author":"W Li","year":"2019","unstructured":"Li W, Meng Y, Wang Y, Cheng X, Wang C, Xiao S, Zhang X, Deng Z, Hu M, Shen P, et al. Association of age and viral factors with high-risk HPV persistence: A retrospective follow-up study. Gynecol Oncol. 2019;154(2):345\u201353.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4378_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijgo.2004.07.013","volume":"87","author":"EM Smith","year":"2004","unstructured":"Smith EM, Johnson SR, Ritchie JM, Feddersen D, Wang D, Turek LP, Haugen TH. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet. 2004;87(2):131\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4378_CR30","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1038\/s41598-025-87568-6","volume":"15","author":"A Abate","year":"2025","unstructured":"Abate A, Munshea A, Nibret E, Alemayehu DH, Alemu A, Abdissa A, Mihret A, Abebe M, Mulu A. Persistence and clearance rates of human papillomaviruses in a cohort of women treated or not treated for cervical dysplasia in northwest Ethiopia. Sci Rep. 2025;15(1):8218.","journal-title":"Sci Rep"},{"issue":"1","key":"4378_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jiph.2020.11.011","volume":"14","author":"M Li","year":"2021","unstructured":"Li M, Liu T, Luo G, Sun X, Hu G, Lu Y, Zou RHX, Luo H. Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007\u20132018: A retrospective cohort study. J Infect Public Health. 2021;14(1):42\u20139.","journal-title":"J Infect Public Health"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04378-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04378-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04378-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:15:05Z","timestamp":1783570505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04378-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04378-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hefei Maternal and Child Health Hospital Ethics Committee approved the protocol (Ethical No.: YYLL2018-2018xjk127-04-01), and the trial was registered with the Chinese Clinical Trial Registry (ChiCTR2100045911). All participants provided informed consent after being informed of study procedures and objectives. The study adhered to the Declaration of Helsinki, ethical guidelines, and protected participants\u2019 rights and confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}